Better banking

How the Human Cancer Models Initiative is building a bank of better cell models

Preclinical experiments using established cancer cell lines are notoriously poor predictors of clinical efficacy, but the cells are more cost-effective and widely available than patient-derived tumor samples. Raising the bar on both quality and accessibility, NIH's National Cancer Institute (NCI) has joined with three publicly funded international organizations to form

Read the full 504 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE